
Integra LifeSciences Holdings Corporation IART
$ 9.1
1.0%
Quarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Total Shareholders Equity 2011-2026 | IART
Annual Total Shareholders Equity Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.55 B | 1.59 B | 1.8 B | 1.68 B | 1.51 B | 1.42 B | 1.38 B | 962 M | 840 M | 751 M | 704 M | 666 M | 518 M | 493 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 B | 493 M | 1.13 B |
Quarterly Total Shareholders Equity Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.04 B | 1.52 B | 1.52 B | 1.53 B | 1.6 B | 1.58 B | 1.68 B | 1.67 B | 1.8 B | 1.72 B | 1.66 B | 1.62 B | 1.68 B | 1.63 B | 1.57 B | 1.53 B | 1.51 B | 1.51 B | 1.51 B | 1.51 B | 1.42 B | 1.42 B | 1.42 B | 1.42 B | 1.38 B | 1.38 B | 1.38 B | 1.38 B | 962 M | 962 M | 962 M | 962 M | 840 M | 840 M | 840 M | 840 M | 751 M | 751 M | 751 M | 751 M | 704 M | 704 M | 704 M | 704 M | 666 M | 666 M | 666 M | 666 M | 518 M | 518 M | 518 M | 518 M | 493 M | 493 M | 493 M | 493 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 B | 493 M | 1.11 B |
Total Shareholders Equity of other stocks in the Medical devices industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
5.12 M | $ 2.22 | 5.21 % | $ 3.47 M | ||
|
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
5.23 M | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
1.52 B | $ 10.45 | 0.29 % | $ 1.41 B | ||
|
Cognyte Software Ltd.
CGNT
|
198 M | $ 8.36 | -0.24 % | $ 600 M | ||
|
Alphatec Holdings
ATEC
|
12.4 M | $ 13.05 | 3.57 % | $ 1.96 B | ||
|
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | ||
|
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
169 M | $ 4.27 | 9.21 % | $ 904 M | ||
|
BIOLASE
BIOL
|
-247 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
24.2 B | $ 71.2 | 2.02 % | $ 105 B | ||
|
EDAP TMS S.A.
EDAP
|
40.9 M | $ 4.06 | 2.53 % | $ 151 M | ||
|
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
1.03 B | $ 37.34 | -0.16 % | $ 1.16 B | ||
|
Cytosorbents Corporation
CTSO
|
11.1 M | $ 0.68 | 4.61 % | $ 37 M | ||
|
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | ||
|
ClearPoint Neuro
CLPT
|
28 M | $ 11.16 | 1.18 % | $ 302 M | ||
|
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | ||
|
Establishment Labs Holdings
ESTA
|
23.5 M | $ 65.01 | 2.41 % | $ 1.93 B | ||
|
Neovasc
NVCN
|
1.98 M | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
150 M | $ 18.45 | 0.16 % | $ 121 M | ||
|
InMode Ltd.
INMD
|
683 M | $ 13.65 | 1.64 % | $ 882 M | ||
|
GBS
GBS
|
3 M | - | -0.57 % | $ 7.12 M | ||
|
Abbott Laboratories
ABT
|
52.1 B | $ 110.71 | 0.69 % | $ 193 B | ||
|
Delcath Systems
DCTH
|
111 M | $ 9.74 | -0.71 % | $ 349 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
189 M | $ 2.6 | 0.39 % | $ 153 M | ||
|
Bio-Rad Laboratories
BIO
|
6.57 B | $ 269.48 | 3.15 % | $ 7.6 B | ||
|
Helius Medical Technologies
HSDT
|
2.35 M | $ 2.17 | -0.91 % | $ 1.32 M | ||
|
AxoGen
AXGN
|
129 M | $ 32.75 | -0.27 % | $ 1.51 B | ||
|
Align Technology
ALGN
|
3.85 B | $ 176.12 | 3.94 % | $ 13.2 B | ||
|
Bruker Corporation
BRKR
|
1.78 B | $ 33.74 | 2.99 % | $ 5.03 K | ||
|
BioSig Technologies
BSGM
|
-1.54 M | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
14.5 M | $ 3.74 | 1.91 % | $ 154 M | ||
|
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
81.2 M | $ 0.39 | -6.07 % | $ 40.1 M | ||
|
IRIDEX Corporation
IRIX
|
9.52 M | $ 1.33 | - | $ 21.5 M | ||
|
IRadimed Corporation
IRMD
|
94.6 M | $ 102.8 | 1.09 % | $ 1.31 B |